Doom Loop in Commercial Real Estate Does Not Mean Investors Should Stay Away...Or Does It???

Continue to Keep an Eye on the VIX - A Spring Coil Loading

Is Biotech Dependent on M&A For Returns Now?

Biotech & MedTech Capital Markets Update - 120 Biotech Transactions YTD

Record Biotech Financing Has Increased Competition but Not Necessarily Winners

A Hurricane Can Be Just a Press Release Away - When the FDA Comes, the Wind Blows

Is All-Weather a Reasonable Set-Up for a Portfolio? What Is All-Weather?

The Hidden Value of Municipal Bonds - Munis or Treasuries???

Everyone is Looking for Good News - Can Biotech Deliver?

Is There a Case for Residential Real Estate?

The Secrets are in the Data - Keys to Predicting Winners and Losers

Profiting from Obesity Drugs - A Growth Market

Obesity Drugs Pushing AI for the BIG Winner

Philadelphia Gathering - Can and Should You Utilize Alternatives?

Testing the Lows but Looking at Highs - Biotech in the Spotlight

Biotech M&A Activity Continues - Biogen Acquired Reata for a 59% Premium